Lumida
/DYN
⌘K
Dyne Therapeutics Inc

Dyne Therapeutics Inc

DYN
$18.21USD-1.14%-0.21 today

MARKET CAP

3.4B

P/E (TTM)

FWD P/E

DAY RANGE

$18 – $19

52W RANGE

$12
$27

AI Summary

Stalk
TrimMedium

The asset has decisively broken key horizontal support, shifting the medium-term bias bearish under a Stage 3 distribution outlook. Near-term price is oversold and extended below all major EMAs, so optimal execution should be deferred until a relief rally back into the prior support zone around 21.46–19.88, where resistance is likely to cap supply. While the long-term trend remains structurally up, near-term momentum favors selective trimming into rallies.

  • High 13F ownership signals strong hedge fund confidence
  • Positive momentum with share price up on recent trends
  • Earnings yield at –2.15% and profitability score –2.42 signal poor returns
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICTREND
Sales, Adj.
YoY %
P / Sales
EV / Sales
Gross Profit, Adj.
YoY %
Margin %
EV / Gross Profit
EBITDA, Adj.
YoY %
Margin %
EV / EBITDA
EBIT
YoY %
Margin %
EV / EBIT
Net Income
YoY %
Net Margin
EPS (GAAP)
YoY %